| 1 |
35139477 | Synthesis and evaluation of tofacitinib analogs designed to mitigate metabolic activation. | 2022 Apr |
2 |
| 2 |
34069798 | Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats. | 2021 May 18 |
1 |
| 3 |
31833760 | "Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4": Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping. | 2020 Feb 17 |
7 |
| 4 |
32367507 | Critical Assessment of Pharmacokinetic Drug-Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment. | 2020 Aug |
1 |
| 5 |
32469513 | Reply to Letter to Editor from Veeravalli and Dash on "Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4: Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping". | 2020 Jul 20 |
1 |
| 6 |
31414593 | Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4. | 2019 Sep 16 |
1 |
| 7 |
27138968 | Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers. | 2016 Sep |
1 |
| 8 |
24464803 | The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans. | 2014 Apr |
1 |
| 9 |
27128233 | Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects. | 2014 Jan |
2 |
| 10 |
22233204 | Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data. | 2012 Jul |
4 |